Crossmark

CD163+ macrophages in the triple-negative breast tumor microenvironment are associated with improved survival in the Women’s Circle of Health Study and the Women’s Circle of Health Follow-Up Study

Crossref DOI link: https://doi.org/10.1186/s13058-024-01831-8

Published Online: 2024-05-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Omilian, Angela R.

Cannioto, Rikki

Mendicino, Lucas

Stein, Leighton

Bshara, Wiam

Qin, Bo

Bandera, Elisa V.

Zeinomar, Nur

Abrams, Scott I.

Hong, Chi-Chen

Yao, Song

Khoury, Thaer

Ambrosone, Christine B.
Funding

Funding for this research was provided by:

National Cancer Institute (R03 CA238792, R01 CA185623, R01 CA247281, R01 CA185623, R01 CA247281, R01 CA247281)

Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute (No. HHSN261201300021I)

National Program of Cancer Registries (NPCR), Centers for Disease Control and Prevention (NU5U58DP006279-02-00)

Breast Cancer Research Foundation
License Information

Text and Data Mining valid from 2024-05-08

Version of Record valid from 2024-05-08
More Information

Article History

Received: 16 February 2024

Accepted: 25 April 2024

First Online: 8 May 2024

Declarations

:

: All women provided informed consent and the study protocol was approved by the Institutional Review Boards at Rutgers Cancer Institute of New Jersey and Roswell Park Comprehensive Cancer Center.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below